Comparison of commercial dosimetric software platforms in patients treated with (177)Lu‐DOTATATE for peptide receptor radionuclide therapy

PURPOSE: The aim of this study was to quantitatively compare five commercial dosimetric software platforms based on the analysis of clinical datasets of patients who benefited from peptide receptor radionuclide therapy (PRRT) with (177)Lu‐DOTATATE (LUTATHERA(®)). METHODS: The dosimetric analysis was...

Descripción completa

Detalles Bibliográficos
Autores principales: Mora‐Ramirez, Erick, Santoro, Lore, Cassol, Emmanuelle, Ocampo‐Ramos, Juan C., Clayton, Naomi, Kayal, Gunjan, Chouaf, Soufiane, Trauchessec, Dorian, Pouget, Jean‐Pierre, Kotzki, Pierre‐Olivier, Deshayes, Emmanuel, Bardiès, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
COMPUTATIONAL AND EXPERIMENTAL DOSIMETRY
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589428/
https://www.ncbi.nlm.nih.gov/pubmed/32632928
http://dx.doi.org/10.1002/mp.14375

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589428/
https://www.ncbi.nlm.nih.gov/pubmed/32632928
http://dx.doi.org/10.1002/mp.14375

Ejemplares similares